These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6179747)

  • 1. Unilateral dopamine deficit and lateral eeg asymmetry: sleep abnormalities in hemi-Parkinson's patients.
    Myslobodsky M; Mintz M; Ben-Mayor V; Radwan H
    Electroencephalogr Clin Neurophysiol; 1982 Aug; 54(2):227-31. PubMed ID: 6179747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous asymmetric circling behavior in hemi-parkinsonism; a human equivalent of the lesioned-circling rodent behavior.
    Bracha HS; Shults C; Glick SD; Kleinman JE
    Life Sci; 1987 Mar; 40(11):1127-30. PubMed ID: 3821375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive dopamine and hypocretin deficiencies in Parkinson's disease: is there an impact on sleep and wakefulness?
    Wienecke M; Werth E; Poryazova R; Baumann-Vogel H; Bassetti CL; Weller M; Waldvogel D; Storch A; Baumann CR
    J Sleep Res; 2012 Dec; 21(6):710-7. PubMed ID: 22747735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of melatonin on sleep disorders in a monkey model of Parkinson's disease.
    Belaid H; Adrien J; Karachi C; Hirsch EC; François C
    Sleep Med; 2015 Oct; 16(10):1245-51. PubMed ID: 26429753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polysomnographic measures in Parkinson's disease: a comparison between patients with and without REM sleep disturbances.
    Wetter TC; Trenkwalder C; Gershanik O; Högl B
    Wien Klin Wochenschr; 2001 Apr; 113(7-8):249-53. PubMed ID: 11383385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asymmetric dopamine loss differentially affects effort to maximize gain or minimize loss.
    Porat O; Hassin-Baer S; Cohen OS; Markus A; Tomer R
    Cortex; 2014 Feb; 51():82-91. PubMed ID: 24267688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Handedness leads to interhemispheric EEG asymmetry during sleep in the rat.
    Vyazovskiy VV; Tobler I
    J Neurophysiol; 2008 Feb; 99(2):969-75. PubMed ID: 18077659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study.
    Vardi J; Glaubman H; Rabey J; Streifler M
    J Neural Transm; 1979; 45(4):307-16. PubMed ID: 490153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sleep-wake disturbances in the premotor and early stage of Parkinson's disease.
    Bargiotas P; Schuepbach MW; Bassetti CL
    Curr Opin Neurol; 2016 Dec; 29(6):763-772. PubMed ID: 27798423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paradoxical effect of dopamine medication on cognition in Parkinson's disease: relationship to side of motor onset.
    Hanna-Pladdy B; Pahwa R; Lyons KE
    J Int Neuropsychol Soc; 2015 Apr; 21(4):259-70. PubMed ID: 25923830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain MRI morphometric analysis in Parkinson's disease patients with sleep disturbances.
    Radziunas A; Deltuva VP; Tamasauskas A; Gleizniene R; Pranckeviciene A; Petrikonis K; Bunevicius A
    BMC Neurol; 2018 Jun; 18(1):88. PubMed ID: 29925331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compromised circadian function in Parkinson's disease: enucleation augments disease severity in the unilateral model.
    Willis GL; Kelly AM; Kennedy GA
    Behav Brain Res; 2008 Nov; 193(1):37-47. PubMed ID: 18547659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of hemi-spatial and hemi-motor impairments in a unilateral primate model of Parkinson's disease.
    Milton AL; Marshall JW; Cummings RM; Baker HF; Ridley RM
    Behav Brain Res; 2004 Apr; 150(1-2):55-63. PubMed ID: 15033279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EEG sleep study in parkinsonian patients under bromocryptine treatment.
    Rabey J; Vardi J; Glaubman H; Streifler M
    Eur Neurol; 1978; 17(6):345-50. PubMed ID: 744200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time for a strategy in night-time dopaminergic therapy? An objective sensor-based analysis of nocturnal hypokinesia and sleeping positions in Parkinson's disease.
    Sringean J; Anan C; Thanawattano C; Bhidayasiri R
    J Neurol Sci; 2017 Feb; 373():244-248. PubMed ID: 28131197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sleep-wake functions and quality of life in patients with subthalamic deep brain stimulation for Parkinson's disease.
    Bargiotas P; Eugster L; Oberholzer M; Debove I; Lachenmayer ML; Mathis J; Pollo C; Schüpbach WMM; Bassetti CL
    PLoS One; 2017; 12(12):e0190027. PubMed ID: 29253029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Night-time sleep in Parkinson's disease - the potential use of Parkinson's KinetiGraph: a prospective comparative study.
    Klingelhoefer L; Rizos A; Sauerbier A; McGregor S; Martinez-Martin P; Reichmann H; Horne M; Chaudhuri KR
    Eur J Neurol; 2016 Aug; 23(8):1275-88. PubMed ID: 27160044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of L-DOPA on night sleep in parkinsonian patients].
    Kendel K; Beck U; Wita C; Hohneck E; Zimmermann H
    Arch Psychiatr Nervenkr (1970); 1972; 216(1):82-100. PubMed ID: 4341587
    [No Abstract]   [Full Text] [Related]  

  • 19. Dopamine asymmetry interacts with medication to affect cognition in Parkinson's disease.
    Tomer R; Aharon-Peretz J; Tsitrinbaum Z
    Neuropsychologia; 2007 Jan; 45(2):357-67. PubMed ID: 16876208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine agonists and sleep in Parkinson's disease.
    Cantor CR; Stern MB
    Neurology; 2002 Feb; 58(4 Suppl 1):S71-8. PubMed ID: 11909988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.